Home LiteratureArticle Details
PMID: 12551977 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Mucosal priming of simian immunodeficiency virus-specific cytotoxic T-lymphocyte responses in rhesus macaques by the Salmonella type III secretion antigen delivery system.

Journal of virology ·Vol. 77 ·No. 4 ·2003-02-00 ·Pages 2400-9

Evans DT, Chen LM, Gillis J, Lin KC, Harty B, Mazzara GP, Donis RO, Mansfield KG, Lifson JD, Desrosiers RC, Galán JE, Johnson RP

Abstract

Nearly all human immunodeficiency virus (HIV) infections are acquired mucosally, and the gut-associated lymphoid tissues are important sites for early virus replication. Thus, vaccine strategies designed to prime virus-specific cytotoxic T lymphocyte (CTL) responses that home to mucosal compartments may be particularly effective at preventing or containing HIV infection. The Salmonella type III secretion system has been shown to be an effective approach for stimulating mucosal CTL responses in mice. We therefore tested DeltaphoP-phoQ attenuated strains of Salmonella enterica serovar Typhimurium and S. enterica serovar Typhi expressing fragments of the simian immunodeficiency virus (SIV) Gag protein fused to the type III-secreted SopE protein for the ability to prime virus-specific CTL responses in rhesus macaques. Mamu-A*01(+) macaques were inoculated with three oral doses of recombinant Salmonella, followed by a peripheral boost with modified vaccinia virus Ankara expressing SIV Gag (MVA Gag). Transient low-level CTL responses to the Mamu-A*01 Gag(181-189) epitope were detected following each dose of Salmonella. After boosting with MVA Gag, strong Gag-specific CTL responses were consistently detected, and tetramer staining revealed the expansion of Gag(181-189)-specific CD8(+) T-cell responses in peripheral blood. A significant percentage of the Gag(181-189)-specific T-cell population in each animal also expressed the intestinal homing receptor alpha4beta7. Additionally, Gag(181-189)-specific CD8(+) T cells were detected in lymphocytes isolated from the colon. Yet, despite these responses, Salmonella-primed/MVA-boosted animals did not exhibit improved control of virus replication following a rectal challenge with SIVmac239. Nevertheless, this study demonstrates the potential of mucosal priming by the Salmonella type III secretion system to direct SIV-specific cellular immune responses to the gastrointestinal mucosa in a primate model.

MeSH Terms
AIDS Vaccines/genetics,immunology Animals Bacterial Proteins/genetics,immunology,metabolism Digestive System/immunology Gene Products, gag/genetics,immunology,metabolism Histocompatibility Antigens Class I/metabolism Humans Immunity, Mucosal Immunization Immunization, Secondary Lymphocyte Activation Macaca mulatta Recombination, Genetic Salmonella/genetics,immunology Simian Acquired Immunodeficiency Syndrome/prevention & control Simian Immunodeficiency Virus/immunology T-Lymphocytes, Cytotoxic/immunology Vaccinia virus/genetics,immunology
Chemicals
AIDS Vaccines Bacterial Proteins Gene Products, gag Histocompatibility Antigens Class I Mamu-A 01 antigen SopE protein, Salmonella
Authors & Affiliations
12 authors, click to expand affiliations / ORCID
Evans David T
New England Regional Primate Research Center, Harvard Medical School, One Pine Hill Drive, Southborough, MA 01772-9102, USA.
Chen Li-Mei
Gillis Jacqueline
Lin Kuei-Chin
Harty Brian
Mazzara Gail P
Donis Ruben O
Mansfield Keith G
Lifson Jeffrey D
Desrosiers Ronald C
Galán Jorge E
Johnson R Paul
References (41)
41 references, click to expand
  1. Identifying the target cell in primary simian immunodeficiency virus (SIV) infection: highly activated memory CD4(+) T cells are rapidly eliminated in early SIV infection in vivo.
    J Virol. 2000 Jan;74(1):57-64 PMID: 10590091
  2. Immunization with live attenuated simian immunodeficiency virus induces strong type 1 T helper responses and beta-chemokine production.
    Proc Natl Acad Sci U S A. 1999 Nov 23;96(24):14031-6 PMID: 10570193
  3. Induction of AIDS virus-specific CTL activity in fresh, unstimulated peripheral blood lymphocytes from rhesus macaques vaccinated with a DNA prime/modified vaccinia virus Ankara boost regimen.
    J Immunol. 2000 May 1;164(9):4968-78 PMID: 10779808
  4. Vaccine protection against simian immunodeficiency virus by recombinant strains of herpes simplex virus.
    J Virol. 2000 Sep;74(17):7745-54 PMID: 10933680
  5. Induction of mucosal homing virus-specific CD8(+) T lymphocytes by attenuated simian immunodeficiency virus.
    J Virol. 2000 Sep;74(18):8762-6 PMID: 10954580
  6. Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination.
    Science. 2000 Oct 20;290(5491):486-92 PMID: 11039923
  7. Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine.
    Science. 2001 Apr 6;292(5514):69-74 PMID: 11393868
  8. Prime-boost immunization with DNA vaccine: mucosal route of administration changes the rules.
    J Immunol. 2001 May 1;166(9):5473-9 PMID: 11313385
  9. An effective AIDS vaccine based on live attenuated vesicular stomatitis virus recombinants.
    Cell. 2001 Sep 7;106(5):539-49 PMID: 11551502
  10. Role of CD8(+) lymphocytes in control of simian immunodeficiency virus infection and resistance to rechallenge after transient early antiretroviral treatment.
    J Virol. 2001 Nov;75(21):10187-99 PMID: 11581387
  11. Mucosal AIDS vaccine reduces disease and viral load in gut reservoir and blood after mucosal infection of macaques.
    Nat Med. 2001 Dec;7(12):1320-6 PMID: 11726972
  12. Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity.
    Nature. 2002 Jan 17;415(6869):331-5 PMID: 11797011
  13. Rhesus macaque resistance to mucosal simian immunodeficiency virus infection is associated with a postentry block in viral replication.
    J Virol. 2002 Jun;76(12):6016-26 PMID: 12021334
  14. Immunization of rhesus macaques with a DNA prime/modified vaccinia virus Ankara boost regimen induces broad simian immunodeficiency virus (SIV)-specific T-cell responses and reduces initial viral replication but does not prevent disease progression following challenge with pathogenic SIVmac239.
    J Virol. 2002 Jul;76(14):7187-202 PMID: 12072518
  15. A tissue-specific endothelial cell molecule involved in lymphocyte homing.
    Nature. 1988 Jan 7;331(6151):41-6 PMID: 3340147
  16. Virulence and vaccine potential of phoP mutants of Salmonella typhimurium.
    Microb Pathog. 1989 Jun;6(6):433-43 PMID: 2671582
  17. Generation of hybrid genes and proteins by vaccinia virus-mediated recombination: application to human immunodeficiency virus type 1 env.
    J Virol. 1990 Dec;64(12):5948-57 PMID: 2243381
  18. The complete nucleotide sequence of a pathogenic molecular clone of simian immunodeficiency virus.
    AIDS Res Hum Retroviruses. 1990 Nov;6(11):1221-31 PMID: 2078405
  19. Mapping of deletions in the genome of the highly attenuated vaccinia virus MVA and their influence on virulence.
    J Gen Virol. 1991 May;72 ( Pt 5):1031-8 PMID: 2033387
  20. Definition of an epitope and MHC class I molecule recognized by gag-specific cytotoxic T lymphocytes in SIVmac-infected rhesus monkeys.
    J Immunol. 1991 Jul 1;147(1):320-9 PMID: 1711081
  21. Construction of versatile low-copy-number vectors for cloning, sequencing and gene expression in Escherichia coli.
    Gene. 1991 Apr;100:195-9 PMID: 2055470
  22. Formation of lentivirus particles by mammalian cells infected with recombinant fowlpox virus.
    AIDS Res Hum Retroviruses. 1991 Dec;7(12):991-8 PMID: 1667477
  23. Alpha 4 beta 7 integrin mediates lymphocyte binding to the mucosal vascular addressin MAdCAM-1.
    Cell. 1993 Jul 16;74(1):185-95 PMID: 7687523
  24. Role of alpha 4-integrins in lymphocyte homing to mucosal tissues in vivo.
    J Immunol. 1994 Apr 1;152(7):3282-93 PMID: 7511642
  25. Titration and characterization of two rhesus-derived SIVmac challenge stocks.
    AIDS Res Hum Retroviruses. 1994 Feb;10(2):213-20 PMID: 8198874
  26. Salmonellae as oral vaccine carriers.
    Dev Biol Stand. 1995;84:245-53 PMID: 7796961
  27. Highly attenuated HIV type 2 recombinant poxviruses, but not HIV-2 recombinant Salmonella vaccines, induce long-lasting protection in rhesus macaques.
    AIDS Res Hum Retroviruses. 1995 Aug;11(8):909-20 PMID: 7492438
  28. Vaccine protection by a triple deletion mutant of simian immunodeficiency virus.
    J Virol. 1996 Jun;70(6):3724-33 PMID: 8648707
  29. Homing of naive and memory T lymphocyte subsets to Peyer's patches, lymph nodes, and spleen.
    J Immunol. 1997 Aug 15;159(4):1746-52 PMID: 9257836
  30. Immunization of Macaca mulatta with aroA attenuated Salmonella typhimurium expressing the SIVp27 antigen.
    J Med Primatol. 1997 Feb-Apr;26(1-2):44-50 PMID: 9271188
  31. Expression of mucosal homing receptor alpha4beta7 by circulating CD4+ cells with memory for intestinal rotavirus.
    J Clin Invest. 1997 Sep 1;100(5):1204-8 PMID: 9276738
  32. A high frequency of Mamu-A*01 in the rhesus macaque detected by polymerase chain reaction with sequence-specific primers and direct sequencing.
    Tissue Antigens. 1997 Dec;50(6):657-61 PMID: 9458122
  33. Mucosal immunization with HIV-1 peptide vaccine induces mucosal and systemic cytotoxic T lymphocytes and protective immunity in mice against intrarectal recombinant HIV-vaccinia challenge.
    Proc Natl Acad Sci U S A. 1998 Feb 17;95(4):1709-14 PMID: 9465081
  34. Characterization of the peptide binding motif of a rhesus MHC class I molecule (Mamu-A*01) that binds an immunodominant CTL epitope from simian immunodeficiency virus.
    J Immunol. 1998 Jun 15;160(12):6062-71 PMID: 9637523
  35. Delivery of epitopes by the Salmonella type III secretion system for vaccine development.
    Science. 1998 Jul 24;281(5376):565-8 PMID: 9677200
  36. Chemical inactivation of retroviral infectivity by targeting nucleocapsid protein zinc fingers: a candidate SIV vaccine.
    AIDS Res Hum Retroviruses. 1998 Oct;14 Suppl 3:S311-9 PMID: 9814959
  37. Recombinant, attenuated Salmonella typhimurium stimulate lymphoproliferative responses to SIV capsid antigen in rhesus macaques.
    Vaccine. 1999 Feb 26;17(7-8):923-32 PMID: 10067699
  38. Type III secretion machines: bacterial devices for protein delivery into host cells.
    Science. 1999 May 21;284(5418):1322-8 PMID: 10334981
  39. Effective induction of simian immunodeficiency virus-specific cytotoxic T lymphocytes in macaques by using a multiepitope gene and DNA prime-modified vaccinia virus Ankara boost vaccination regimen.
    J Virol. 1999 Sep;73(9):7524-32 PMID: 10438842
  40. Gastrointestinal tract as a major site of CD4+ T cell depletion and viral replication in SIV infection.
    Science. 1998 Apr 17;280(5362):427-31 PMID: 9545219
  41. Vaccination of macaques against pathogenic simian immunodeficiency virus with Venezuelan equine encephalitis virus replicon particles.
    J Virol. 2000 Jan;74(1):371-8 PMID: 10590126
Article Info
Journal
Journal of virology
Abbr.
J Virol
ISSN
0022-538X
Published
2003-02-00
Pages
2400-9
Language
English
Region
United States
NLM ID
0113724
PMCID
PMC141091
Subset
IM
Grants
NCRR NIH HHS · RR 00168 · United States
NIAID NIH HHS · AI 10464 · United States
NCRR NIH HHS · P51 RR000168 · United States
NCRR NIH HHS · K26 RR000168 · United States
NIAID NIH HHS · AI 45314 · United States
NCI NIH HHS · N01 CO 12400 · United States
NIAID NIH HHS · R01 AI046953 · United States
NIAID NIH HHS · AI 46953 · United States
NIAID NIH HHS · AI 35365 · United States
NCI NIH HHS · N01CO12400 · United States
NIAID NIH HHS · P01 AI035365 · United States
NIAID NIH HHS · U01 AI035365 · United States
NIAID NIH HHS · F32 AI010464 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com